Related references
Note: Only part of the references are listed.Long-term outcomes of lobectomy for papillary thyroid carcinoma with high-risk features
S. Xu et al.
BRITISH JOURNAL OF SURGERY (2021)
Detecting Recurrence Following Lobectomy for Thyroid Cancer: Role of Thyroglobulin and Thyroglobulin Antibodies
Amit Ritter et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Total thyroidectomy versus lobectomy for intermediate-risk papillary thyroid carcinoma: A single-institution matched-pair analysis
Jie Liu et al.
ORAL ONCOLOGY (2019)
Lobectomy Is Feasible for 1-4 cm Papillary Thyroid Carcinomas: A 10-Year Propensity Score Matched-Pair Analysis on Recurrence
Eyun Song et al.
THYROID (2019)
Dynamic risk stratification system in post-lobectomy low-risk and intermediate-risk papillary thyroid carcinoma patients
Jae Won Cho et al.
CLINICAL ENDOCRINOLOGY (2018)
Changes in Serum Thyroglobulin Levels After Lobectomy in Patients with Low-Risk Papillary Thyroid Cancer
Suyeon Park et al.
THYROID (2018)
Dynamic Risk Stratification for Predicting Recurrence in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine Remnant Ablation Therapy
Suyeon Park et al.
THYROID (2017)
Dynamic Risk Stratification in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine
Denise P. Momesso et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
Bryan R. Haugen et al.
THYROID (2016)
Extent of Surgery for Papillary Thyroid Cancer Is Not Associated With Survival An Analysis of 61,775 Patients
Mohamed Abdelgadir Adam et al.
ANNALS OF SURGERY (2014)
Update on Differentiated Thyroid Cancer Staging
Denise P. Momesso et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2014)
Thyroid Lobectomy Is Associated with Excellent Clinical Outcomes in Properly Selected Differentiated Thyroid Cancer Patients with Primary Tumors Greater Than 1 cm
Fernanda Vaisman et al.
JOURNAL OF THYROID RESEARCH (2013)
Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancer
F. Vaisman et al.
CLINICAL ENDOCRINOLOGY (2011)
Estimating Risk of Recurrence in Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation: Using Response to Therapy Variables to Modify the Initial Risk Estimates Predicted by the New American Thyroid Association Staging System
R. Michael Tuttle et al.
THYROID (2010)
Share Paper
